溯聯股份(301397.SZ):重慶一工廠近期進行了較大幅度的產能升級
格隆匯12月1日丨溯聯股份(301397.SZ)近期在接待機構投資者調研時表示,公司目前產能充足,由於公司總部和研發中心搬遷至新的區域,重慶一工廠近期進行了較大幅度的產能升級。加上預期在2024年2季度投入使用的江蘇溧陽的過渡工廠,完全能夠滿足明年增長所需產能要求。公司的管路系統產品所需的工藝和設備和燃油車產品基本一致,可以利用柔性產線進行多品種的共線化生產。但產線頻繁切換會導致效率下降和原材料浪費,因此在產能充足的情況下還是以專線生產為主。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.